A breakthrough in bioelectronic medicine has emerged from a collaborative effort between NYU Abu Dhabi and the Cleveland Clinic Abu…
Read More
Viatris Expands Into Non-Opioid Pain Market With $1.65bn Acquisition of Pacira BioSciences
The global pharmaceutical landscape is undergoing a profound structural shift as healthcare enterprises aggressively pivot away from traditional opioid-based narcotics…
Read More
Widely used joint pain supplement glucosamine linked to accelerated cognitive decline in new University of Florida study
A common, over-the-counter supplement long favored by aging populations to combat joint discomfort and osteoarthritis may pose an unforeseen risk…
Read More
New Brain Circuitry Discovery Offers Potential Breakthrough for Treating Chronic Neuropathic Pain
Deep inside the complex architecture of the human brain, a small, specialized cluster of nerve cells serves as a critical…
Read More
Restoring Healthy Mitochondria Offers Potential New Pathway for Treating Chronic Nerve Pain and Addressing Underlying Causes of Neuropathy
Chronic nerve pain, a condition that affects millions of individuals globally, often manifests as an agonizing sensitivity where even the…
Read More
Restoring Mitochondrial Health Offers New Paradigm for Treating Chronic Nerve Pain and Diabetic Neuropathy
The landscape of chronic pain management is facing a potential shift as researchers at the Duke University School of Medicine…
Read More
Unlocking the Neural Switch: University of Colorado Researchers Identify Brain Circuit Responsible for the Transition to Chronic Pain
A breakthrough study from the University of Colorado Boulder has identified a specific neural pathway that acts as a gatekeeper…
Read More
Investigating the causes of rheumatoid arthritis pain
Stockholm, Sweden – Researchers at the esteemed Karolinska Institutet in Stockholm, Sweden, have achieved a significant breakthrough in understanding the…
Read More
VERTANICAL’s Investigational Non-Opioid Chronic Low Back Pain Treatment VER-01 Receives FDA Breakthrough Therapy Designation
VERTANICAL has announced a significant milestone in its development of VER-01, an investigational non-opioid therapeutic candidate for chronic low back…
Read More
AMSBIO Reports Karolinska Institutet’s Groundbreaking Research Using AAV Products to Uncover Neural Basis of Rheumatoid Arthritis Pain
AMSBIO, a leading provider of life science reagents and services, has announced its involvement in a pivotal research endeavor by…
Read More
